211 related articles for article (PubMed ID: 26561950)
1. Predicting drug resistance in adult patients with generalized epilepsy: A case-control study.
Voll A; Hernández-Ronquillo L; Buckley S; Téllez-Zenteno JF
Epilepsy Behav; 2015 Dec; 53():126-30. PubMed ID: 26561950
[TBL] [Abstract][Full Text] [Related]
2. Multivariable prediction model of drug resistance in adult patients with generalized epilepsy from Colombia: A case-control study.
Orozco-Hernández JP; Quintero-Moreno JF; Marín-Medina DS; Valencia-Vásquez A; Villada HC; Lizcano A; Martínez JW
Epilepsy Behav; 2018 Nov; 88():176-180. PubMed ID: 30290326
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in patients with refractory idiopathic generalized epilepsy.
Gomez-Ibañez A; McLachlan RS; Mirsattari SM; Diosy DC; Burneo JG
Epilepsy Res; 2017 Feb; 130():69-73. PubMed ID: 28157601
[TBL] [Abstract][Full Text] [Related]
4. Predictors of drug-resistance in epilepsy with auditory features.
Zhang L; Zhu X; Peng A; Lai W; He S; Qiu X; Zou X; Chen L
Epilepsy Res; 2020 Aug; 164():106353. PubMed ID: 32447239
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and outcome of idiopathic generalized epilepsy in adults.
Gesche J; Christensen J; Hjalgrim H; Rubboli G; Beier CP
Eur J Neurol; 2020 Apr; 27(4):676-684. PubMed ID: 31838768
[TBL] [Abstract][Full Text] [Related]
6. Risk factors associated with drug resistant focal epilepsy in adults: A case control study.
Roy PL; Ronquillo LH; Ladino LD; Tellez-Zenteno JF
Seizure; 2019 Dec; 73():46-50. PubMed ID: 31734466
[TBL] [Abstract][Full Text] [Related]
7. Drug-resistant idiopathic generalized epilepsy: A meta-analysis of prevalence and risk factors.
Jiang T; Zhang X; Zhang M; Liu M; Zhu H; Sun Y
Epilepsy Behav; 2023 Sep; 146():109364. PubMed ID: 37523796
[TBL] [Abstract][Full Text] [Related]
8. Jeavons Syndrome: Clinical Features and Response to Treatment.
Smith KM; Youssef PE; Wirrell EC; Nickels KC; Payne ET; Britton JW; Shin C; Cascino GD; Patterson MC; Wong-Kisiel LC
Pediatr Neurol; 2018 Sep; 86():46-51. PubMed ID: 30082241
[TBL] [Abstract][Full Text] [Related]
9. Resistance to valproic acid as predictor of treatment resistance in genetic generalized epilepsies.
Gesche J; Khanevski M; Solberg C; Beier CP
Epilepsia; 2017 Apr; 58(4):e64-e69. PubMed ID: 28230254
[TBL] [Abstract][Full Text] [Related]
10. Drug-resistant epilepsy in adults: Outcome trajectories after failure of two medications.
Choi H; Hayat MJ; Zhang R; Hirsch LJ; Bazil CW; Mendiratta A; Kato K; Javed A; Legge AW; Buchsbaum R; Resor S; Heiman GA
Epilepsia; 2016 Jul; 57(7):1152-60. PubMed ID: 27265407
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of the modified Atkins diet for adults with idiopathic generalized epilepsy.
Kverneland M; Selmer KK; Nakken KO; Iversen PO; Taubøll E
Epilepsy Behav; 2015 Dec; 53():197-201. PubMed ID: 26588588
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors of drug-resistant epilepsy in children presenting under 2 years of age: experience of a tertiary center in Turkey.
Yildiz EP; Gunes D; Bektas G; Aksu Uzunhan T; Tatli B; Caliskan M; Aydinli N; Ozmen M
Acta Neurol Belg; 2018 Mar; 118(1):71-75. PubMed ID: 29063291
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in epileptic encephalopathies at onset in the first 2 years of life: The experience of a tertiary healthcare center in Italy.
Pellino G; Chiavarino F; Fiumana E; Boni A; Russo A; Faggioli R
Epilepsy Behav; 2019 Oct; 99():106465. PubMed ID: 31421519
[TBL] [Abstract][Full Text] [Related]
14. Natural course and predictors of spontaneous seizure remission in idiopathic generalized epilepsy: 7-27 years of follow-up.
von Podewils F; Lapp S; Wang ZI; Hartmann U; Herzer R; Kessler C; Runge U
Epilepsy Res; 2014 Sep; 108(7):1221-7. PubMed ID: 24907182
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of epilepsy with onset in the first three years of life: Findings from a large cohort of patients.
Vignoli A; Peron A; Turner K; Scornavacca GF; La Briola F; Chiesa V; Zambrelli E; Canevini MP
Eur J Paediatr Neurol; 2016 Jul; 20(4):566-72. PubMed ID: 27071723
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for drug-resistant epilepsy: A systematic review and meta-analysis.
Xue-Ping W; Hai-Jiao W; Li-Na Z; Xu D; Ling L
Medicine (Baltimore); 2019 Jul; 98(30):e16402. PubMed ID: 31348240
[TBL] [Abstract][Full Text] [Related]
17. A scale for prediction of response to AEDs in patients with MRI-negative epilepsy.
Yang SJ; He GN; Han X; Wang N; Chen Y; Zhu XR; Ma BQ; Li MM; Zhao P; Chen YN; Zhao T; Ma H
Epilepsy Behav; 2019 May; 94():41-46. PubMed ID: 30884406
[TBL] [Abstract][Full Text] [Related]
18. Predictors of medical intractability in children with epilepsy onset during the first two years of life, excluding infantile epileptic spasm syndrome.
Yıldırım M; Altıntaş M; Uysal E; Bektaş Ö; Teber S
Seizure; 2024 Apr; 117():206-212. PubMed ID: 38479206
[TBL] [Abstract][Full Text] [Related]
19. Quantifying the burden of generalized tonic-clonic seizures in patients with drug-resistant epilepsy.
Sheikh SR; Thompson N; Frech F; Malhotra M; Jehi L
Epilepsia; 2020 Aug; 61(8):1627-1637. PubMed ID: 32658343
[TBL] [Abstract][Full Text] [Related]
20. Clinical and EEG factors associated with antiseizure medication resistance in idiopathic generalized epilepsy.
Kamitaki BK; Janmohamed M; Kandula P; Elder C; Mani R; Wong S; Perucca P; O'Brien TJ; Lin H; Heiman GA; Choi H
Epilepsia; 2022 Jan; 63(1):150-161. PubMed ID: 34705264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
